18F-JNJ-64326067
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-JNJ-64326067, covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants [Phase 1]